A study by Althobiti et al. [22] assessed LIV1 mRNA expression and copy-number alterations using the METABRIC cohort (n = 1980) as well as immunohistochemistry in a large (n = 670) and annotated series of early-stage (I–III) operable BC. The gene discussed is SLC39A6; the disease is breast cancer.